Literature DB >> 25930154

Primary High-Grade Poorly Differentiated Angiosarcoma of an Intra-parotid Lymph Node.

Eugenia Ducharne-Asuaje1, Dominique Dorion2, Louis Lamarre3, Jean Michel Coindre4, Sameh Geha5.   

Abstract

Head and neck angiosarcoma is an infrequent malignant vascular tumor most commonly found in the skin and soft tissue of the head and neck. Most head and neck angiosarcomas are metastatic to cervical lymph nodes from other primitive location. We describe herein a case of primary high-grade poorly differentiated angiosarcoma arising in an intra-parotid lymph node, discuss the value of immunohistochemical stains for differential diagnosis, and review the literature concerning head and neck angiosarcoma. A 47-year-old man presented with a painless mass that had grown for a period of 6 months in the parotid area. The CT-scan revealed a left parotid lesion of 17 mm. Fine needle aspiration was considered suspicious for lymphoma or poorly differentiated carcinoma. A superficial parotidectomy was performed. On gross examination, the lesion was a well-defined, gray, homogeneous mass of 15 mm of diameter. Microscopic examination showed a normal parotid tissue and a poorly differentiated malignant neoplasm in an intra-parotid lymph node. The tumor had a pseudo-alveolar pattern, with large pleomorphic epithelioid cells, abundant eosinophilic cytoplasm, large vesicular nuclei, and one or more prominent nucleoli. Atypical mitoses were seen. Neoplastic malignant cells stained positive for Vimentin, CD31, D2-40, factor VIII, ERG, and partially for CD34. A positron emission tomography scan was made to search for a primary neoplasia, but no other tumor was localized. The diagnosis of primary high-grade, poorly differentiated, intra-parotid lymph node angiosarcoma was established.

Entities:  

Keywords:  Lymph node tumour; Markers of vascular tumors; Poorly differentiated angiosarcoma; Primary angiosarcoma

Mesh:

Substances:

Year:  2015        PMID: 25930154      PMCID: PMC4838960          DOI: 10.1007/s12105-015-0631-3

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  7 in total

1.  Primary vascular tumors of lymph nodes other than Kaposi's sarcoma. Analysis of 39 cases and delineation of two new entities.

Authors:  J K Chan; G Frizzera; C D Fletcher; J Rosai
Journal:  Am J Surg Pathol       Date:  1992-04       Impact factor: 6.394

2.  ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma.

Authors:  Markku Miettinen; Zeng-Feng Wang; Anders Paetau; Shyh-Han Tan; Albert Dobi; Shiv Srivastava; Isabell Sesterhenn
Journal:  Am J Surg Pathol       Date:  2011-03       Impact factor: 6.394

3.  Primary low-grade angiosarcoma of the cervical lymph node.

Authors:  Asli Sahin Yilmaz; Cagatay Oysu; Seza Tetikkurt; Aslihan Semiz-Oysu
Journal:  J Otolaryngol Head Neck Surg       Date:  2012-08

Review 4.  Immunohistochemistry of soft tissue tumours - review with emphasis on 10 markers.

Authors:  Markku Miettinen
Journal:  Histopathology       Date:  2013-11-28       Impact factor: 5.087

5.  ERG protein expression in human tumors detected with a rabbit monoclonal antibody.

Authors:  Oksana Yaskiv; Brian P Rubin; Huiying He; Sara Falzarano; Cristina Magi-Galluzzi; Ming Zhou
Journal:  Am J Clin Pathol       Date:  2012-12       Impact factor: 2.493

6.  ERG expression in epithelioid sarcoma: a diagnostic pitfall.

Authors:  Markku Miettinen; Zengfeng Wang; Maarit Sarlomo-Rikala; Ziedulla Abdullaev; Svetlana D Pack; John F Fetsch
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

7.  Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients.

Authors:  Y Fong; D G Coit; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  1993-01       Impact factor: 12.969

  7 in total
  1 in total

1.  Tingible body macrophages.

Authors:  Suhasini Palakshappa Gotur; Vijay Wadhwan
Journal:  J Oral Maxillofac Pathol       Date:  2021-01-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.